Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) LT-Debt-to-Total-Asset: 0.01 (As of Mar. 2026)

What is Gen Ilac Veglik Urunlerinayi ve Ticaret AS LT-Debt-to-Total-Asset?

Gen Ilac Veglik Urunlerinayi ve Ticaret AS IST:GENIL -1.29% 87 LT-Debt-to-Total-Asset is 0.01 as of Mar. 2026. GuruFocus rates IST:GENIL with a GF Score™ of 87/100 and a GF Value™ of ₺8.12 (Modestly Overvalued). The stock has 5 warning signs investors should review.

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's long-term debt to total assests ratio for the quarter that ended in Mar. 2026 was 0.01.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's long-term debt to total assets ratio declined from Mar. 2025 (0.03) to Mar. 2026 (0.01). It may suggest that Gen Ilac Veglik Urunlerinayi ve Ticaret AS is progressively becoming less dependent on debt to grow their business.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS LT-Debt-to-Total-Asset Related Terms

Gen Ilac Veglik Urunlerinayi ve Ticaret AS LT-Debt-to-Total-Asset Historical Data

* Premium members only.

The historical data trend for Gen Ilac Veglik Urunlerinayi ve Ticaret AS's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS LT-Debt-to-Total-Asset Chart

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.01

0.02

0.01

0.04

0.01

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															0.03	0.02	0.02	0.01	0.01

87GF Score

Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS IST:GENIL

LT-Debt-to-Total-Asset is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Gen Ilac Veglik Urunlerinayi ve Ticaret AS LT-Debt-to-Total-Asset Calculation

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as

LT Debt to Total Assets (A: Dec. 2025 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2025 )	/	Total Assets (A: Dec. 2025 )
	=	239.828	/	19450.351
	=	0.01

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2026 is calculated as

LT Debt to Total Assets (Q: Mar. 2026 )	=	Long-Term Debt & Capital Lease Obligation (Q: Mar. 2026 )	/	Total Assets (Q: Mar. 2026 )
	=	295.544	/	22309.55
	=	0.01

Frequently Asked Questions Learn more about LT-Debt-to-Total-Asset →

What does a LT-Debt-to-Total-Asset of 0.01 mean?

Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) has a LT-Debt-to-Total-Asset of 0.01 as of Mar. 2026. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Gen Ilac Veglik Urunlerinayi ve Ticaret AS and its competitors.

Is Gen Ilac Veglik Urunlerinayi ve Ticaret AS's LT-Debt-to-Total-Asset too high?

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's current LT-Debt-to-Total-Asset is 0.01. Overall, Gen Ilac Veglik Urunlerinayi ve Ticaret AS has a GF Score™ of 87/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Gen Ilac Veglik Urunlerinayi ve Ticaret AS's LT-Debt-to-Total-Asset compare to ZTS and UTHR?

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's LT-Debt-to-Total-Asset of 0.01 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good LT-Debt-to-Total-Asset for a Drug Manufacturers company?

A good LT-Debt-to-Total-Asset depends on the Drug Manufacturers industry context. However, LT-Debt-to-Total-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high LT-Debt-to-Total-Asset mean?

A high LT-Debt-to-Total-Asset can signal that a stock is expensive relative to its fundamentals. Long-term Debt to Total Asset ratio is the ratio of total long-term debt to total assets. View historical data on Gen Ilac Veglik Urunlerinayi ve Ticaret AS and its competitors. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's current LT-Debt-to-Total-Asset is 0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Gen Ilac Veglik Urunlerinayi ve Ticaret AS stock overvalued right now?

Based on GuruFocus' analysis, Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) is currently considered Modestly Overvalued. The stock's GF Value™ is ₺8.12, compared to a current price of ₺9.20 — trading 13.3% above its estimated fair value. The current LT-Debt-to-Total-Asset is 0.01. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's overall GF Score™ is 87/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is LT-Debt-to-Total-Asset calculated?

LT-Debt-to-Total-Asset is calculated from a company's financial statements. For Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL), the current LT-Debt-to-Total-Asset is 0.01 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Overvalued in 2026?

Based on GuruFocus' analysis, Gen Ilac Veglik Urunlerinayi ve Ticaret AS stock appears to be overvalued. The current stock price of ₺9.20 is trading 13.3% above its estimated GF Value™ of ₺8.12. GuruFocus considers Gen Ilac Veglik Urunlerinayi ve Ticaret AS to be Modestly Overvalued.

Key valuation signals for IST:GENIL:

LT-Debt-to-Total-Asset: 0.01
GF Value™: ₺8.12 vs. price of ₺9.20 (13.3% above fair value)
GF Score™: 87/100 with 5 warning signs

No single metric tells the full story. See the IST:GENIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies IST:ECILC IST:DEVA IST:TRILC XTER:MRK XSWX:GALD TSE:4502 SHSE:600276 NSE:SUNPHARMA LSE:HLN XTAE:TEVA XSWX:SDZ ZTS UTHR HKSE:03692 VTRS NSE:DIVISLAB OSTO:SOBI NBIX NSE:TORNTPHARM SHSE:688506

Address Mustafa Kemal Mahallesi 2119.Sk. No:3, Cankaya, Ankara, TUR, 06520

Website https://www.genilac.com.tr

Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS is a specialty pharmaceuticals company in Turkey. Its locally manufactured products include Cajex, Contra-K, Epamor, Genkort, Ilopera, among others, while imported products include AvonexPEN, Plegridy, Tecfidera, Regen-D among others.

87GF Score

Get the complete analysis for IST:GENIL

LT-Debt-to-Total-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₺9.20

Price

₺8.12

GF Value

View IST:GENIL Analysis

See LT-Debt-to-Total-Asset data for all stocks →